Abpro Holdings (ABPO) Change in Taxes (2022 - 2025)
Abpro Holdings' (ABPO) quarterly Change in Taxes came in at -$425000.0 in Q3 2025, down 1636.85% YoY from $27654.0 in Q3 2024, and down 43850.36% on a QoQ basis from -$967.0 in Q4 2024.
Abpro Holdings (ABPO) Change in Taxes (2022 - 2025) Analysis & Trends
Abpro Holdings (ABPO) has 4 years of Change in Taxes data on file, last reported at -$425000.0 in Q3 2025.
- Quarterly Change in Taxes fell 1636.85% year-over-year to -$425000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$398313.0 (down 798.79% YoY) and the FY2025 annual result came in at -$366000.0, down 742.11% from the prior year.
- Change in Taxes slipped to -$425000.0 in Q3 2025, from -$967.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $679998.0 in Q1 2023 to a low of -$1.7 million in Q4 2023.
- A 4-year average of -$6020.5 and a median of $27654.0 in 2024 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2024 — Change in Taxes surged 99.94% — and 2025, when it slumped 1636.85%.
- Tracing ABPO's Change in Taxes over 4 years: stood at $530538.0 in 2022, then plunged by 423.41% to -$1.7 million in 2023, then surged by 99.94% to -$967.0 in 2024, then sank by 43850.36% to -$425000.0 in 2025.
- The last three Change in Taxes figures came in at -$425000.0 (Q3 2025), -$967.0 (Q4 2024), and $27654.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -425,000.00 |
| Sep 30, 2025 | -425,000.00 |
| Dec 31, 2024 | -967.00 |
| Dec 31, 2024 | -967.00 |
| Sep 30, 2024 | 27,654.00 |
| Sep 30, 2024 | 27,654.00 |
| Jun 30, 2024 | 26,173.00 |
| Jun 30, 2024 | 26,173.00 |
| Mar 31, 2024 | 4,140.00 |
| Mar 31, 2024 | 4,140.00 |
| Dec 31, 2023 | -1.72 Mn |
| Dec 31, 2023 | -1.72 Mn |
| Sep 30, 2023 | 202,372.00 |
| Sep 30, 2023 | 202,372.00 |
| Jun 30, 2023 | 317,643.00 |
| Jun 30, 2023 | 317,643.00 |
| Mar 31, 2023 | 679,998.00 |
| Mar 31, 2023 | 679,998.00 |
| Dec 31, 2022 | 530,538.00 |
| Dec 31, 2022 | 530,538.00 |